Safety and Immunogenicity of a Recombinant Outer Surface Protein A Lyme Vaccine

JAMA: The Journal of the American Medical Association

Volumn 271, Issue 22, 1994, Pages 1764-1768

  Keller, David ^a   Koster, Frederick T ^a   Marks, Donald H ^b   Hosbach, Philip ^b   Erdile, Lorne F ^b   Mays, John P ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b Connaught Laboratories Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; HLA DR2 ANTIGEN; HLA DR4 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; LIPOPROTEIN A; RECOMBINANT PROTEIN; VACCINE;

ADULT; AGED; ARTHRALGIA; ARTICLE; BORRELIA BURGDORFERI; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; DRUG SAFETY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; INJECTION PAIN; INTRAMUSCULAR DRUG ADMINISTRATION; JOINT STIFFNESS; LYME DISEASE; MALE; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROLOGY; VACCINATION;

EID: 0028236921     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1994.03510460056033     Document Type: Article

References (31)

1. Barbour AG, Fish D. The biological and social phenomenon of Lyme disease. Science. 1993;260: 1610-1616.
2. Barbour AG. The diagnosis of Lyme disease: rewards and perils. Ann Intern Med. 1989;110:501-502.
3. Cooke WD, Dattwyler RJ. Spirochetal arthritis, including Lyme disease. Curr Opin Rheumatol. 1990;2:622-627.
4. Duffy J. Lyme disease. Ann Allergy. 1990;65:1-13.
5. Barbour AG. Laboratory aspects of Lyme borreliosis. Clin Microbiol Rev. 1988;1:399-414.
6. Centers for Disease Control and Prevention. Lyme disease. MMWR Morb Mortal Wkly Rep. 1993;42:345-348.
7. Feder H, Gerber M, Krause P, et al. Early Lyme disease: a flu-like illness without erythema migrans. Pediatrics. 1993;91:456-459.
8. Johnson RC, Kodner C, Russell M. Active immunization of hamsters against experimental infection with Borrelia burgdorferi. Infect Immun. 1986;54:897-898.
9. Johnson RC, Kodner C, Russell M. Passive immunization of hamsters against experimental infection with Borrelia burgdorferi. Infect Immun. 1986;53:713-714.
10. Schmitz JL, Schell RF, Hejka AG, et al. Passive immunization prevents induction of Lyme arthritis in LSH hamsters. Infect Immun. 1990;58:144-148.
11. Aberer E, Brunner C, Suchanek G, et al. Molecular mimicry and Lyme borreliosis: shared antigenic determinant between Borrelia burgdorferi and human tissue. Ann Neurol. 1989;26:732-737.
12. Sigal LH. Cross-reactivity between Borrelia burgdorferi flagellin and a human axonal 64,000 molecular weight protein. J Infect Dis. 1993;167: 1372-1378.
13. Bergstrom S, Bundoc VG, Barbour AG. Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol. 1989;3:479-486.
14. Brandt ME, Riley BS, Radolf JD, et al. Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins. Infect Immun. 1990; 58:983-991.
15. Fikrig E, Barthold SW, Kantor FS, et al. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science. 1990; 250:553-556.
16. Schaible UE, Kramer MD, Eichmann K, et al. Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (SCID) mice. Proc Natl Acad Sci U S A. 1990;87:3768-3772.
17. Simon MM, Schaible UE, Kramer MD, et al. Recombinant outer surface protein A from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J Infect Dis. 1991; 164:123-132.
18. Erdile LF, Brandt MA, Warakomski DJ, et al. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect Immun. 1993;61:81-90.
19. Steere AC, Dwyer E, Winchester R. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med. 1990;161:1203-1209.
20. Kalish RA, Leong JM, Steere AC. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun. 1993; 61:2774-2779.
21. Sadziene A, Thompson PA, Barbour AG. In vitro inhibition of Borrelia burgdorferi growth by antibodies. J Infect Dis. 1993;167:165-172.
22. Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med. 1984;57:521-525.
23. Craft JE, Fischer DK, Shimamoto GT, et al. Antigens of Borrelia burgdorferi recognized during Lyme disease: appearance of a new IgM response and expansion of the IgG response late in illness. J Clin Invest. 1986;78:934-939.
24. Coleman JL, Benach JL. Isolation of antigenic components from the Lyme disease spirochete: their role in early diagnosis. J Infect Dis. 1987;155:756-765.
25. Dressler F, Whalen JA, Reinhardt BN, et al. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis. 1993;167:392-400.
26. Roehrig JT, Piesman J, Hunt AR, et al. The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms. J Immunol. 1992; 149:3648-3653.
27. Gern L, Schaible UE, Simon MM. Mode of inoculation of the Lyme disease agent Borrelia burgdorferi influences infection and immune responses in inbred strains of mice. J Infect Dis. 1993;167: 971-975.
28. Callister SM, Schell RF, Case KL, et al. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test. J Infect Dis. 1993;167:158-164.
29. Bessler WG, Suhr B, Buhring HJ, et al. Specific antibodies elicited by antigen covalently linked to a synthetic adjuvant. Immunobiology. 1985;170:239-244.
30. Deres K, Schild H, Weismuller KH, et al. In vivo priming of virus-specific cytotoxic T lymphocytes with a synthetic lipopeptide vaccine. Nature. 1989;342:561-564.
31. Defoort JP, Nardelli B, Huang W, et al. Macromolecular assemblage in the design of a synthetic AIDS vaccine. Proc Natl Acad Sci U S A. 1992; 89:3879-3883.